PT Kimia Farma (Persero) Tbk (KAEF.JK)
IDR 396.0
(0.51%)
IDR 396.0
(0.51%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 17585.29 Billion IDR | -13.6% |
| 2022 | 20353.99 Billion IDR | 14.6% |
| 2021 | 17760.19 Billion IDR | 1.12% |
| 2020 | 17562.81 Billion IDR | -4.3% |
| 2019 | 18352.87 Billion IDR | 94.0% |
| 2018 | 9460.42 Billion IDR | 55.19% |
| 2017 | 6096.14 Billion IDR | 32.16% |
| 2016 | 4612.56 Billion IDR | 42.53% |
| 2015 | 3236.22 Billion IDR | 9.03% |
| 2014 | 2968.18 Billion IDR | 20.08% |
| 2013 | 2471.93 Billion IDR | 19.05% |
| 2012 | 2076.34 Billion IDR | 15.72% |
| 2011 | 1794.24 Billion IDR | 8.26% |
| 2010 | 1657.29 Billion IDR | 6.06% |
| 2009 | 1562.62 Billion IDR | 8.09% |
| 2008 | 1445.66 Billion IDR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 17067.2 Billion IDR | -1.59% |
| 2024 Q3 | 16802.34 Billion IDR | -1.55% |
| 2024 Q1 | 17343.27 Billion IDR | -1.38% |
| 2023 FY | 17585.29 Billion IDR | -13.6% |
| 2023 Q4 | 17585.29 Billion IDR | 95.7% |
| 2023 Q3 | 8986.05 Billion IDR | -56.38% |
| 2023 Q2 | 20599.66 Billion IDR | 1.99% |
| 2023 Q1 | 20197.16 Billion IDR | -0.77% |
| 2022 Q1 | 17924.83 Billion IDR | 0.93% |
| 2022 Q4 | 20353.99 Billion IDR | 9.09% |
| 2022 FY | 20353.99 Billion IDR | 14.6% |
| 2022 Q2 | 18415.46 Billion IDR | 2.74% |
| 2022 Q3 | 18658.37 Billion IDR | 1.32% |
| 2021 Q2 | 17783.23 Billion IDR | 1.82% |
| 2021 FY | 17760.19 Billion IDR | 1.12% |
| 2021 Q1 | 17465.89 Billion IDR | -0.55% |
| 2021 Q4 | 17760.19 Billion IDR | -5.76% |
| 2021 Q3 | 18845.33 Billion IDR | 5.97% |
| 2020 Q4 | 17562.81 Billion IDR | -0.71% |
| 2020 FY | 17562.81 Billion IDR | -4.3% |
| 2020 Q3 | 17687.65 Billion IDR | 0.99% |
| 2020 Q2 | 17513.99 Billion IDR | 1.83% |
| 2020 Q1 | 17199.59 Billion IDR | -6.28% |
| 2019 Q4 | 18352.87 Billion IDR | 2.74% |
| 2019 FY | 18352.87 Billion IDR | 94.0% |
| 2019 Q1 | 11647.07 Billion IDR | 23.11% |
| 2019 Q2 | 16797.52 Billion IDR | 44.22% |
| 2019 Q3 | 17862.64 Billion IDR | 6.34% |
| 2018 Q2 | 7941.52 Billion IDR | 22.27% |
| 2018 FY | 9460.42 Billion IDR | 55.19% |
| 2018 Q1 | 6494.96 Billion IDR | 6.54% |
| 2018 Q4 | 9460.42 Billion IDR | 9.67% |
| 2018 Q3 | 8626.24 Billion IDR | 8.62% |
| 2017 Q3 | 5682.87 Billion IDR | 14.25% |
| 2017 Q2 | 4974.12 Billion IDR | 10.96% |
| 2017 Q1 | 4482.69 Billion IDR | -2.82% |
| 2017 FY | 6096.14 Billion IDR | 32.16% |
| 2017 Q4 | 6096.14 Billion IDR | 7.27% |
| 2016 Q3 | 4292.45 Billion IDR | 12.58% |
| 2016 Q4 | 4612.56 Billion IDR | 7.46% |
| 2016 Q1 | 3669.39 Billion IDR | 13.39% |
| 2016 Q2 | 3812.87 Billion IDR | 3.91% |
| 2016 FY | 4612.56 Billion IDR | 42.53% |
| 2015 Q2 | 2980.07 Billion IDR | 5.7% |
| 2015 Q1 | 2819.37 Billion IDR | -5.01% |
| 2015 FY | 3236.22 Billion IDR | 9.03% |
| 2015 Q3 | 3166.6 Billion IDR | 6.26% |
| 2015 Q4 | 3236.22 Billion IDR | 2.2% |
| 2014 Q4 | 2968.18 Billion IDR | 8.26% |
| 2014 Q3 | 2741.8 Billion IDR | 5.79% |
| 2014 Q2 | 2591.66 Billion IDR | 13.67% |
| 2014 Q1 | 2279.98 Billion IDR | -7.77% |
| 2014 FY | 2968.18 Billion IDR | 20.08% |
| 2013 Q2 | 2143.3 Billion IDR | 5.94% |
| 2013 Q4 | 2471.93 Billion IDR | 6.2% |
| 2013 FY | 2471.93 Billion IDR | 19.05% |
| 2013 Q3 | 2327.52 Billion IDR | 8.6% |
| 2013 Q1 | 2023.11 Billion IDR | -2.56% |
| 2012 Q3 | 2083.88 Billion IDR | 8.73% |
| 2012 Q4 | 2076.34 Billion IDR | -0.36% |
| 2012 Q1 | 1843.88 Billion IDR | 2.77% |
| 2012 FY | 2076.34 Billion IDR | 15.72% |
| 2012 Q2 | 1916.5 Billion IDR | 3.94% |
| 2011 FY | 1794.24 Billion IDR | 8.26% |
| 2011 Q4 | 1794.24 Billion IDR | 0.0% |
| 2010 FY | 1657.29 Billion IDR | 6.06% |
| 2009 FY | 1562.62 Billion IDR | 8.09% |
| 2008 FY | 1445.66 Billion IDR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 10955.84 Billion IDR | -60.511% |
| PT Itama Ranoraya Tbk | 1058.88 Billion IDR | -1560.735% |
| PT Millennium Pharmacon International Tbk | 1639.68 Billion IDR | -972.482% |
| PT Soho Global Health Tbk | 4746.96 Billion IDR | -270.454% |